mitochondria

Researchers report a technique for coating mitochondria without harming the organelles, a step that could open new ways to address mitochondrial dysfunction, which is linked to a range of diseases and ageing. Details of the method and its potential applications are drawing interest from the biomedical research community.

Luciole Pharmaceuticals is drawing attention as a biotech startup focused on mitochondrial DNA therapeutics, listed as affiliated with Oregon Health & Science University. The company works on treatments aimed at mitochondria, the energy-producing structures in cells whose genetic defects cause a range of rare and serious diseases. Details on funding, clinical programs and leadership remain limited, with observers watching whether the OHSU connection signals a pipeline of university research moving toward drug development.